Schizophrenia is a mental disease that affects 1% of the world’s population and has a suicide rate 20 times higher than that of the general population. this pathology, particularly devastating for young people between 16 and 30 years.

“Schizophrenia” from the Greek schizo, “separated”, and phrên “spirit”.
symptoms of this psychosis are classified into two categories:

Positive symptoms “produce” delusions, hallucinations, disorders of the course of thought, incomprehensible behaviors.
Negative symptoms are dominated by “deficits” of communication: withdrawal, decreased ability to communicate with others and to share the same rational repository, lack of motivation, emotional and motor disharmony leading to a disruption of social functioning that may go to total isolation.
Today, we know that schizophrenia is a neuro-developmental psychosis manifesting itself at the end of the maturation of the brain and expressing a deficit of development of the central nervous system.

What are the treatments and therapeutic research pathways?
Drug treatments by neuroleptics, but also by other psychotropic drugs such as antidepressants, thymo-regulators and tranquillizers.

Psychoanalytic psychotherapy may be suitable for psychologically structured patients.

Cognitive-behavioral psychotherapies aim to facilitate the development of new social and relational skills in patients who are very poor in this area.

Group therapies are adapted to patients whose severity of the disease makes it difficult to manage individually.

Family therapies or some simplified interventions with parents, aim to correct some family dysfunctions.